Last reviewed · How we verify
NCT05380817
Stanford Kids CAMP Study
NA trial testing Remote Monitoring Program in Pre-diabetes in 100 participants. Status unknown.
31 August 2022
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 July 2022 |
| Primary completion | 31 August 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Remote Monitoring Program
Conditions studied
- Pre-diabetes — all drugs for Pre-diabetes →
- Obesity — all drugs for Obesity →
- Type-2 Diabetes Mellitus — all drugs for Type-2 Diabetes Mellitus →
Sponsor
Stanford University
Who can join
Adults 5 to 13, any sex, with Pre-diabetes or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Stanford Kids CAMP study aims to evaluate the feasibility of enrolling minority participants in school age children (5-13 years old) in a community summer camp setting along with the efficiency by which each participant's biologic specimens are collected. Using remote monitoring technologies and through partnering with community-based organizations, the investigators hypothesize that an increase in underrepresented minority participation in a clinical trial that is greater than the national average is possible.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05380817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pre-diabetes
Currently open trials in the same condition.
- NCT07189234 — Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health · Phase 2 · recruiting
- NCT07079722 — More Health Less Diabetes · NA · recruiting
- NCT07125365 — UK Islet Autoantibody Registry · recruiting
- NCT06862128 — OGTT at Home Using CGM vs at the Clinic · NA · recruiting
- NCT07021144 — VA|PREVENTION: Randomized Controlled Trial of a Person-Centred Digital Intervention to Prevent Diabetes in High-Risk Adu · NA · active not recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05380817 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 19 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05380817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing